Zobrazeno 1 - 10
of 50
pro vyhledávání: '"M Herman Chui"'
Autor:
M Herman Chui, Ciyu Yang, Nikita Mehta, Vikas Rai, Ahmet Zehir, Amir Momeni Boroujeni, Marc Ladanyi, Diana Mandelker
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 8, Iss 1, Pp 14-18 (2022)
Abstract TP53 is one of the most ubiquitously altered genes in human cancer. The biological impact of rare variants, particularly those located within noncoding regions, remains poorly understood. From interrogation of clinical massively parallel seq
Externí odkaz:
https://doaj.org/article/b83220cb08b643ebbfb30e9d28a040ec
Autor:
Melica Nourmoussavi Brodeur, Pier Selenica, Weining Ma, Sara Moufarrij, Christian Dagher, Thais Basili, Nadeem R. Abu‐Rustum, Carol Aghajanian, Qin Zhou, Alexia Iasonos, Lora H. Ellenson, Britta Weigelt, M. Herman Chui
Publikováno v:
Molecular Oncology, Vol 18, Iss 10, Pp 2356-2368 (2024)
Anti‐HER2 therapy is indicated for erb‐b2 receptor tyrosine kinase 2 (ERBB2)‐amplified/overexpressing endometrial carcinoma (EC). Mutations constitute another mode of ERBB2 activation, but only rare ERBB2‐mutated ECs have been reported. We so
Externí odkaz:
https://doaj.org/article/5b6c7d7bf2c04f0080d4461d3815a0fb
Autor:
Sushmita Gordhandas, Arnaud Da Cruz Paula, Elizabeth C. Kertowidjojo, Fresia Pareja, Kimberly Dessources, Edaise M. da Silva, Fatemeh Derakhshan, Jennifer J. Mueller, Nadeem R. Abu-Rustum, M. Herman Chui, Britta Weigelt
Publikováno v:
Gynecologic Oncology Reports, Vol 53, Iss , Pp 101391- (2024)
Externí odkaz:
https://doaj.org/article/8013523ea6fd4a99a7ed9434d3ad1847
Autor:
David Joon Ho, M. Herman Chui, Chad M. Vanderbilt, Jiwon Jung, Mark E. Robson, Chan-Sik Park, Jin Roh, Thomas J. Fuchs
Publikováno v:
Journal of Pathology Informatics, Vol 14, Iss , Pp 100160- (2023)
Deep learning has been widely used to analyze digitized hematoxylin and eosin (H&E)-stained histopathology whole slide images. Automated cancer segmentation using deep learning can be used to diagnose malignancy and to find novel morphological patter
Externí odkaz:
https://doaj.org/article/ac5a85b0b8734246ac67e2c516a8f4e9
Autor:
Anastasia, Navitski, Duaa H, Al-Rawi, Vicky, Makker, Britta, Weigelt, Dmitriy, Zamarin, Ying, Liu, Angela G, Arnold, M Herman, Chui, Diana L, Mandelker, Michael, Walsh, Deborah F, DeLair, Karen A, Cadoo, Roisin E, O'Cearbhaill
Publikováno v:
JCO precision oncology. 6
Autor:
Amir Momeni Boroujeni, Elizabeth Kertowidjojo, Xinyu Wu, Robert Soslow, Sarah Chiang, Edaise da Silva, Britta Weigelt, M. Herman Chui
Publikováno v:
Modern Pathology. 35:1684-1694
Mullerian adenosarcoma is an uncommon mesenchymal tumor of the gynecologic tract, usually of uterine origin. Tumors are generally low-grade and associated with good prognosis, whereas high-grade adenosarcomas are rare and less well studied. Herein, w
Autor:
Rachel N. Grisham, M. Herman Chui
Publikováno v:
Current Oncology Reports. 24:1549-1555
Low-grade serous ovarian cancer (LGSOC) is a rare form of epithelial ovarian cancer that generally exhibits a protracted course and is less sensitive to chemotherapy than high-grade serous ovarian cancer. Over the past decade, it has become clear tha
Autor:
Rachel N. Grisham, M. Herman Chui, Britta Weigelt, Carol Aghajanian, Roisin E. O'Cearbhaill, Dennis S. Chi, Yelena Kemel, Anna Maio, Oliver Zivanovic, Kara Long Roche, Diana Mandelker, Arnaud Da Cruz Paula, Alexia Iasonos, Qin Zhou, Ying L. Liu, Sushmita Gordhandas, Beryl Manning-Geist
Supplementary Data from MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c3e595292667e6cbb8d9f46ddecd1ba
https://doi.org/10.1158/1078-0432.22489278.v1
https://doi.org/10.1158/1078-0432.22489278.v1
Autor:
Rachel N. Grisham, M. Herman Chui, Britta Weigelt, Carol Aghajanian, Roisin E. O'Cearbhaill, Dennis S. Chi, Yelena Kemel, Anna Maio, Oliver Zivanovic, Kara Long Roche, Diana Mandelker, Arnaud Da Cruz Paula, Alexia Iasonos, Qin Zhou, Ying L. Liu, Sushmita Gordhandas, Beryl Manning-Geist
Purpose:To characterize the somatic mutational landscape, investigate associations between genetic alterations and clinical outcomes, and determine the prevalence of pathogenic germline mutations in low-grade serous ovarian carcinomas (LGSC).Experime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78bd9f772755334285f04812fc559c40
https://doi.org/10.1158/1078-0432.c.6532920.v1
https://doi.org/10.1158/1078-0432.c.6532920.v1